Clinical Trial Update: Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic Anemia [Phase 4]

View source ↗

Summary

ClinicalTrials.gov update on a Phase 4 trial evaluating moderate-dose cyclophosphamide for childhood acquired aplastic anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Xiaofan Zhu | Conditions: Aplastic Anemia | Phase 4 | Status: UNKNOWN